Together in practice: take part in UK REACH study
Published on 08 December 2020
Take part in UK REACH, a national research study investigating if, how, and why ethnicity affects Covid-19 clinical outcomes for people working in health and social care.
This morning, our Chief Executive and Registrar, Andrea Sutcliffe, wrote to a sample of half a million nurses and midwives today to invite them to take part in a national research study. The study, called UK REACH, is investigating if, how, and why, ethnicity affects Covid-19 clinical outcomes for those working in health and social care.
The recommendations of this important study may help protect nurses, midwives, nursing associates and other colleagues during the pandemic.
All the information the research team collects is confidential and doesn’t affect professional registration. We won’t even know who is taking part in the study.
If you’re on the main register (you’re not a temporary registrant) and you received a version of the email without the invitation to take part in the research it’s not too late – you can express interest through the UK REACH website.
Andrea’s email also shared our own research, Ambitious for change: research into NMC processes and people’s protected characteristics. This research is an important first step on a long journey of improvement. We take responsibility for the areas we’re responsible for, and we will work with others in health and social care to drive change more widely.
Ambitious for Change was published as part of Together in Practice, our initiative that aims to understand and address inequality and discrimination, and celebrate the contributions of diverse professionals and colleagues.
Read our statement from July 2020, when we shared the news we would be taking part in UK REACH.
Other recent news…
Published on 08 April 2021
Today, we launched a consultation on new draft education standards that build on ambitions for community and public health nursing in the UK.
Published on 01 April 2021
Find out more about the approval
Published on 31 March 2021
Take part in the Royal Pharmaceutical Society's consultation